Mangoceuticals公司宣布,其股东将按照一对一的比例,获得Nuclea的可交换股份,用以置换Mangoceuticals的股票。这一举措标志着两家公司在股权结构上的重要调整。
Mangoceuticals公司宣布,其股东将按照一对一的比例,获得Nuclea的可交换股份,用以置换Mangoceuticals的股票。这一举措标志着两家公司在股权结构上的重要调整。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.